1-L Transcription of SARS-CoV-2 Spike Protein S1 Subunit
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(8), P. 4440 - 4440
Published: April 18, 2024
The
COVID-19
pandemic
prompted
rapid
research
on
SARS-CoV-2
pathogenicity.
Consequently,
new
data
can
be
used
to
advance
the
molecular
understanding
of
infection.
present
bioinformatics
study
discusses
"spikeopathy"
at
level
and
focuses
possible
post-transcriptional
regulation
spike
protein
S1
subunit
in
host
cell/tissue.
A
theoretical
protein-RNA
recognition
code
was
check
compatibility
with
mRNAs
human
transcriptome
(1-L
transcription).
principle
for
this
method
is
elucidated
defined
RNA
binding
GEMIN5
(gem
nuclear
organelle-associated
5)
RNU2-1
(U2
spliceosomal
RNA).
Using
described
here,
it
shown
that
45%
genes/proteins
identified
by
1-L
transcription
are
directly
linked
COVID-19,
39%
indirectly
16%
cannot
currently
associated
COVID-19.
stroke,
diabetes,
cardiac
injury.
Language: Английский
Exploration of the link between COVID-19 and gastric cancer from the perspective of bioinformatics and systems biology
Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: Sept. 20, 2024
Background
Coronavirus
disease
2019
(COVID-19),
an
infectious
caused
by
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2),
has
a
global
pandemic.
Gastric
cancer
(GC)
poses
great
threat
to
people’s
health,
which
is
high-risk
factor
for
COVID-19.
Previous
studies
have
found
some
associations
between
GC
and
COVID-19,
whereas
the
underlying
molecular
mechanisms
are
not
well
understood.
Methods
We
employed
bioinformatics
systems
biology
explore
these
links
Gene
expression
profiles
of
COVID-19
(GSE196822)
(GSE179252)
were
obtained
from
Expression
Omnibus
(GEO)
database.
After
identifying
shared
differentially
expressed
genes
(DEGs)
functional
annotation,
protein-protein
interaction
(PPI)
network,
hub
genes,
transcriptional
regulatory
networks
candidate
drugs
analyzed.
Results
identified
209
DEGs
GC.
Functional
analyses
highlighted
immune-related
pathways
as
key
players
in
both
diseases.
Ten
(
CDK1
,
KIF20A
TPX2
UBE2C
HJURP
CENPA
PLK1
MKI67
IFI6
IFIT2
)
identified.
The
transcription
factor/gene
miRNA/gene
38
factors
(TFs)
234
miRNAs.
More
importantly,
we
ten
potential
therapeutic
agents,
including
ciclopirox,
resveratrol,
etoposide,
methotrexate,
trifluridine,
enterolactone,
troglitazone,
calcitriol,
dasatinib
deferoxamine,
been
reported
improve
treat
Conclusion
This
research
offer
valuable
insights
into
interplay
GC,
potentially
guiding
future
strategies.
Language: Английский
Exploration of the link between COVID-19 and gastric cancer from the perspective of bioinformatics and systems biology
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 4, 2024
Abstract
Background
Coronavirus
disease
2019
(COVID-19),
an
infectious
caused
by
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2),
has
a
global
pandemic.
Gastric
cancer
(GC)
poses
great
threat
to
people’s
health,
which
is
high-
risk
factor
for
COVID-19.
Previous
studies
have
found
some
associations
between
GC
and
COVID-19,
whereas
the
underlying
molecular
mechanisms
are
not
well
understood.
Methods
We
used
bioinformatics
systems
biology
approach
investigate
relationship
The
gene
expression
profiles
of
COVID-19
(GSE196822)
(GSE179252)
were
downloaded
from
Gene
Expression
Omnibus
(GEO)
database.
After
identifying
shared
differentially
expressed
genes
(DEGs)
functional
annotation,
protein-protein
interaction
(PPI)
network,
hub
genes,
transcriptional
regulatory
networks
candidate
drugs
analyzed.
Results
A
total
209
DEGs
identified
explore
linkages
GC.
Functional
analyses
showed
that
Immune-related
pathway
collectively
participated
in
development
progression
In
addition,
there
selected
10
including
CDK1
,
KIF20A
TPX2
UBE2C
HJURP
CENPA
PLK1
MKI67
IFI6
IFIT2
.
transcription
factor/gene
miRNA/gene
38
factors
(TFs)
234
miRNAs.
More
importantly,
we
ten
potential
therapeutic
agents,
ciclopirox,
resveratrol,
etoposide,
methotrexate,
trifluridine,
enterolactone,
troglitazone,
calcitriol,
dasatinib
deferoxamine,
been
reported
improve
treat
This
study
also
provides
insight
into
diseases
most
associated
with
mutual
DEGs,
may
provide
new
ideas
research
on
treatment
Conclusions
possibility
be
contributed
effective
Language: Английский
AS03-adjuvanted H5N1 vaccine enhances immune response by modulating NR4A1, SDC1, ID3 genes, and reducing cortisol
Lairun Jin,
No information about this author
Jingxin Li,
No information about this author
Fengcai Zhu
No information about this author
et al.
Human Vaccines & Immunotherapeutics,
Journal Year:
2024,
Volume and Issue:
20(1)
Published: Nov. 21, 2024
The
AS03-adjuvanted
H5N1
influenza
vaccine
induces
significantly
higher
immune
responses
compared
to
the
non-adjuvanted
vaccine.
However,
immunological
mechanisms
underlying
this
enhancement
remain
unclear.
We
aimed
identify
key
genes
and
pathways
involved
in
response
expression
profiles
of
GSE102012
GSE112293
were
downloaded
from
Gene
Expression
Omnibus
database
differentially
expressed
between
groups.
Subsequently,
Ontology
(GO)
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
pathway
enrichment
analyses
performed
using
Database
for
Annotation,
Visualization,
Integrated
Discovery
online
tool.
protein–protein
interaction
(PPI)
networks
constructed
by
Search
Tool
Retrieval
Interacting
database.
Through
cluster
analysis
PPI
network,
three
hub
genes,
namely
NR4A1,
SDC1,
ID3,
identified
as
pivotal
players
intricate
network
interactions.
ID3
was
up-regulated,
other
two
down-regulated.
results
GO
highlighted
seven
biological
processes,
cellular
components,
molecular
functions
among
genes.
KEGG
revealed
involvement
Cushing
syndrome
pathway.
may
enhance
through
suppressing
NR4A1
gene
SDC1
gene,
upregulating
reducing
cortisol
production
Language: Английский